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Objectives. This study sought to evaluate the diagnostic value 
of the biochemical markers creatine kinase (CK), creatine 
kinase-MB fraction (CK-MB) and cardiac troponin T (cTNT) to 
diagnose acute myocardial infarction (AMI) after cardiopulmo- 
nary resuscitation (CPR). 
Background. Elevations of CK and CK-MB after CPR are a 
frequent finding and might be associated with ischemic myocar- 
dial injury, as well as physical trauma to the chest. 
Methods. Patients who had cardiac arrest and primary success- 
ful resuscitation were included in the study. The diagnosis of AMI 
was confirmed or ruled out by means of typical electrocardio- 
graphic findings, thallium-201 myocardial scintigraphy or au- 
topsy, if death occurred during the hospital period, in 39 primary 
survivors of sudden cardiac death. In 24 patients (62%) the 
diagnosis of AMI was established. Serum cTNT, CK and CK-MB 
were measured, and the CK-MB/CK ratio was calculated on 
admission and after 12 h. 
Results. On admission all markers of myocardial injury proved 
to be weak methods for the diagnosis of AMI. After 12 h cTNT as 
well as CK-MB exhibited a similar diagnostic performance; CK 
and the CK-MB/CK ratio proved to be worthless. Sensitivity and 
specificity for a cTNT cutoff value of 0.6 ng/ml, 12 h after cardiac 
arrest, were 96% and 80%, respectively. For a CK-MB cutoff value 
of 26 U/liter, sensitivity was 96% and specificity was 73%. 
Conclusions. Cardiac TNT and CK-MB are valuable tools in 
detecting AMI as the cause of sudden cardiac death. However, 
there is a considerable lack of sensitivity and specificity. Cardiac 
injury is probably caused not only by AMI, but also by myocardial 
damage related to CPR efforts. 
(J Am Coil Cardiol 1996;28:1220-5) 
Detection or exclusion of acute myocardial infarction (AMI) as 
the cause of sudden cardiac death may be of potential benefit 
for both diagnostic and therapeutic procedures (1). Diagnosis 
of AMI is usually based on history, typical electrocardiographic 
(ECG) changes or elevation of the serum MB fraction of 
creatine kinase (CK-MB) (2). After cardiopulmonary resusci- 
tation (CPR), a history often cannot be obtained and electro- 
cardiography may not be diagnostic because of persistent left 
bundle branch block or non-Q wave infarction. Elevations of 
serum CK and CK-MB after CPR are not only caused by AMI, 
but are also associated with mechanical nd electrical trauma 
to the chest during CPR (3,4). 
Cardiac troponin Y (cTNT), a polypeptide subunit of the 
rnyofibrillar regulatory troponin complex found in striated 
muscles, can be detected by specific monoclonal ntibodies to 
cTNT (5) and is highly sensitive and specific for myocardial 
injury (6). 
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The aim of the present study was to evaluate the diagnostic 
possibilities of the biochemical markers CK, CK-MB and 
cTNT to detect AMI after successful CPR. 
Methods  
Patients. The patients in this study were selected from 
those patients erved by the Department of Emergency Med- 
icine at the Vienna General Hospital, a tertiary care university 
hospital. The study period was from May 1, 1995 through 
December 1, 1995. The performance of this study was ap- 
proved by the local ethics committee. 
Inclusion criteria. Patients more than 18 years of age who 
had a witnessed out of hospital cardiac arrest on ventricular 
fibrillation and received chest compressions and direct current 
countershock during CPR, with a return of spontaneous 
circulation for a duration of 12 h or more, were eligible for 
inclusion in the study. Cardiopulmonary arrest was defined as 
the absence of both spontaneous respiration and palpable 
pulse. Return of spontaneous circulation was defined as electri- 
cal activity on the ECG and palpable pulses. 
Exclusion criteria. Patients who had a history of MI before 
this event were excluded from the study, as were patients 
whose cardiopulmonary arrest was associated with trauma, 
hypothermia, drowning, drug overdose or a primary respira- 
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Abbreviations and Acronyms 
AMI acute myocardial infarction 
CK - creatine kinase 
CK-MB - creatine kinase-MB fraction 
CPR - cardiopulmonary resuscitation 
cTNT - cardiac troponin T 
ECG - electrocardiogram 
IQR = interquartile range 
M1 = myocardial infarction 
SPECT = single-photon emission computed tomography 
tory arrest. To assess whether the patient had a prior history of 
MI, the patient (if he or she had recovered) and/or the 
patient's relatives, as well as the physician, were interviewed. 
Prior MI was presumed if the patient had a history of chest 
pain and documented unequivocal changes on the ECG or 
unequivocal changes in serum enzymes, or both (2). 
Treatment was in accordance with the American Heart 
Association's guidelines for basic and advanced cardiac life 
support and for postresuscitative care (7). All patients received 
standard intensive care treatment such as controlled mechan- 
ical ventilation and sedoanalgesia with midazolam (0.2 mg/kg 
body weight per h), fentanyl (0.004 mg/kg per h) and low dose 
dopamine (1.5/zg/kg per min). Other medications were left to 
the discretion of the attending physician. 
Data collection. Acquisition of out-of-hospital data was 
performed retrospectively on the arrival of each patient ac- 
cording to the "Utstein style," the recommended guidelines for 
uniform reporting of data from out-of-hospital cardiac arrest 
(8). Evaluated ata included time of cardiac arrest, duration of 
the interval from time of collapse to beginning of basic or 
advanced life support, duration of the interval from time of 
collapse to return of spontaneous circulation, out-of-hospital 
medication, first ECG rhythm and the patient's history. The 
interval between recognition of collapse and time of calling the 
emergency medical system was estimated by one of the inves- 
tigators who personally interviewed one or more witnesses. For 
the interval from cardiac arrest to initiation of basic or 
advanced life support, we presumed no sufficient systemic 
blood flow (i.e., duration of no blood flow) (9). The interval 
from initiation of life support o return of spontaneous circu- 
lation was presumed to be representative of duration of low 
blood flow. 
Diagnosis of AMI. The diagnosis of AMI was established if 
one or more of the following tests revealed a positive result. 
Electrocardiography. Acute MI was presumed if the 12-lead 
ECG displayed ST segment elevations >0.2 mV in two pre- 
cordial leads or >0.1 mV in two limb leads and subsequent 
development of Q waves within the hospital stay (10). If the 
ECG was not diagnostic for AMI a myocardial scintigraphy or 
autopsy, or both, was performed. 
Dipyridamole stress thallium-201 single-photon emission 
computed tomography (SPECT) protocol. We chose a dipyrida- 
mole stress thallium-201 SPECT protocol, which was performed 
within 3 weeks after admission, to determine not only AMI but 
also the viability in myocardial segments showing reduced func- 
tion and to detect inducible myocardial ischemia (11) so that 
management of the tested patients could be facilitated. 
All tests were performed inthe morning in the fasting state, 
and the patients were prohibited from having caffeinated 
beverages and coronary and blood pressure medication i the 
24 h before testing. Dipyridamole (Boeringer, lngelheim, 
Germany) was given intravenously (0.7 mg/kg) over 5 min, 
followed by a low level (25 W) bicycle stress test over 4 min, the 
injection of 100 MBq of thallium-201 and continuation of 
bicycle stress for 1 more rain. Single-photon emission com- 
puted tomographic s intigraphy (180 ° rotation, 6o steps, 64 × 
64 matrix, 45 s/frame; no prefiltering, low bandpass-filtered 
backprojection) was performed within 5 rain after thallium-201 
injection and repeated at 3 h of redistribution with a large field 
of view gamma camera equipped with a low energy general- 
purpose collimator. Slices of the left ventricle, reoriented 
according to the short, vertical and horizontal length axes of 
the heart, were visually assessed by two investigators. In 
patients with irreversible segments, SPECT scintigraphy was 
repeated after einjection of 37 MBq of thallium-201. Myocar- 
dial infarction was presumed if the segments were still irre- 
versible after reinjection. 
Autopsy studies. If patients died during their hospital stay, 
autopsy was performed. Cardiac dissection was performed 
according to standard procedures (12). The coronary artery 
tree was examined by transverse cuts at 0.25-cm intervals to 
localize significant stenosis of coronary arteries as well as 
thrombotic events. Ischemic damage to the myocardium was 
evaluated by macroscopic appearance of coagulation necrosis 
and by staining with nitroblue tetrazolium (13). 
Blood sampling. Determination fCKand CK-MB. A com- 
plete series of routine laboratory tests (including CK and 
CK-MB) were performed on arrival and 12 h after cardiac 
arrest. Measurements were carried out with a Hitachi 717 
autoanalyzer (Boehringer, Mannheim, Germany). The upper 
normal value for CK in our laboratory is 80 U/liter, and for 
CK-MB, 10 U/liter. The percentage of the CK-MB/CK ratio 
was calculated. The maximal activity of CK-MB after AMI and 
countershock is to be expected between l0 and 20 h (14-17). 
Determination f cTNT. Blood for the determination of
cTNT was sampled together with blood for routine laboratory 
testing on arrival and 12 h after cardiac arrest. Cardiac TNT 
was measured quantitatively with the ENZYMUN test (Boehr- 
inger, Mannheim, Germany). The maximal sensitivity to diag- 
nose AMI is expected to be achieved approximately 12 h after 
the event (16). 
Statistical analysis. Data are expressed as the median 
value and the interquartile range (IQR). Percentages were 
determined for dichotomous variables. The Mann-Whitney U 
test was used to compare groups of continuous data. The 
Fisher exact est was used to compare dichotomous variables. 
A p value <0.05 was considered statistically significant. 
Sensitivity and specificity were calculated according to 
standard formulas. Receiver operating characteristic urves 
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Figure l. Flow diagram of diagnostic steps to detect myocardial 
infarction (MI) in 39 patients after cardiac arrest and subsequent 
cardiopulmonary resuscitation. I  four of the patients who underwent 
autopsy, MI was confirmed by means of the ECG or thallium-201 
myocardial scintigraphy (dotted lines). 
were constructed to visualize the diagnostic performance (18) 
of serum CK, CK-MB and cTNT on arrival and 12 h after the 
event in the diagnosis of AMI. The Youden index was calcu- 
lated for each cutoff value of each biochemical marker of 
myocardial injury (sensitivity + specificity - 1) (19). The 
closer the Youden index approaches 1, the better is the 
diagnostic performance of a test, thus facilitating the definition 
of a cutoff value. 
All data were computed with Microsoft Excel for Windows, 
version 5.0 and SPSS for Windows, version 6.0. 
Resu l ts  
Within a study period of 6 months, 126 patients were 
admitted to the emergency department because of cardiac 
arrest. A total of 42 patients fulfilled the inclusion criteria. 
Three patients had to be excluded after enrollment because 
their ECG was not diagnostic and neither thallium-201 myo- 
cardial scintigraphy nor autopsy was performed. 
Diagnosis of AMI. In 24 patients (62%) the diagnosis of 
AMI was established (Fig. 1). In four of the patients who 
underwent autopsy, AMI was confirmed by means of electro- 
cardiography or thallium-201 myocardial scintigraphy (dotted 
lines in Fig. i). Patient characteristics, including age and CPR, 
were similar in both groups (Table 1). Concentrations of 
biochemical markers of myocardial injury differed between 
groups on admission (except for CK) and even more 12 h after 
cardiac arrest (Table 2). 
Patients with Q wave M1 versus those with non-Q wave MI. 
Between patients with Q wave MI (n -- 14) and those with 
non-Q wave MI (n = 10) there was no difference according to 
demographic characteristics (age 66 years [IQR 49 to 74] vs. 62 
Table l. Patient Characteristics Concerning Cardiopulmonary 
Resuscitation in Patients With (n = 24) and Without (n = 15) 
Established Acute Myocardial Infarction 
AMI No AMI p 
(n = 24) (n - 15) Value* 
Age (yr) 64 (IQR 51-72) 66 (IQR 45-75) 0.9 
Men 21 (88%) 9 (60%) 0.05 
No flow duration? 2 (IQR <1-6) 3 (IQR <1-10) 0.6 
(min) 
[x)w flow duration:l: 15 (IQR 8-30) 10 (IQR 3-16) (1.2 
(rain) 
Epinephrine (rag) 3 (IQR 0-7) 3 (IQR 0-4) 0.35 
Defibrillation 1580 (IQR 760-2,140) 850 (IQR 400-1,220) 0.06 
energy§ (J) 
*p < 0.05 considered statistically significant. ~Time from collapse to 
initiation of life support. :]:Time from initiation of basic or advanced life support 
therapy to return of spontaneous circulation. §Cumulative amount of energy 
administered during resuscitation. AMI = acute myocardial infarction; IQR = 
interquartile range. 
years [IQR 50 to 67], p = 0.58; 13 males vs. 8 males, p = 0.55) 
or resuscitation baseline data (duration of no blood flow: 5 min 
[IQR <1 to 7] vs. 1 min [<1 to 6], p = 0.36; duration of low 
blood flow: 16 rain [IQR 9 to 29] vs. 14 rain [IQR 6 to 30], p = 
0.93; epinephrine administered uring resuscitation: 5.5 mg 
[IQR 2 to 7] vs. 1 mg [IQR 0 to 7], p = 0.15; cumulative 
amount of energy of defibrillation administered during resus- 
citation: 1,760 J [IQR 738 to 2,275] vs. 1,220 J [IQR 700 to 
1,990], p = 0.46). The location of the infarction was anterior in 
10 patients with Q wave MI and in 8 patients with non-Q wave 
MI (p -- 0.5) and inferior in 4 patients with Q wave MI and in 
2 with non-Q wave M1. There was a nonsignificant trend 
toward higher CK, CK-MB and cTNT values on admission in 
patients later developing Q wave versus non-Q wave MI (CK: 
118 U/liter [IQR 65 to 298] vs. 82 U/liter [IQR 43 to 122], p = 
0.13; CK-MB: 22 U/liter [IQR 3 to 46] vs. 7 U/liter [IQR 2 to 
42], p = 0.46; cTNT: 0.41 ng/ml [IQR 0.07 to 1.15] vs. 0.15 
Table 2. Serum Concentrations of Biochemical Markers at Hospital 
Admission and 12 h After Cardiac Arrest and Subsequent Chest 
Compressions and Defibrillation in Patients With (n = 24) and 
Without (n = 15) Acute Myocardial Infarction 
AMI No AMI p 
(n = 24) (n - 15) Value* 
On admission 
cTNT (ng/ml) 0.23 (IQR 0.0%0.68 
CK (U/liter) 95 (IQR 63-182) 
CK-MB 21 (IQR 3-41) 
(U/liter) 
12 h after CA 
cTNT (ng/ml) 3.86 (IQR 1.92-6.53 
CK (U/liter) 1125 (IQR 665-2,085 
CK-MB 95 (IQR 40-149) 
(U/liter) 
0.05 (IQR 0.02-0.24) 0.04 
54 (IQR 39-133) 0.16 
2 (IQR 2-20) 0.04 
0.27 (IQR 0.21-0.58) <0.0001 
108 (IQR 67-730) 0.004 
14 (IQR 3-40) 0.0002 
*p < 0.05 considered statistically significant. AMI = acute myocardial 
infarction; CA cardiac arrest; CK = creatine kinase; CK-MB - creatine 
kinase-MB fraction; cTNT - cardiac troponin T; IQR = interquartile range. 
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Figure 2. Receiver operating characteristic curves of CK, CK-MB, 
CK-MB/CK ratio (CK-MB%) and cTNT on admission for the diag- 
nosis of AMI after cardiac arrest and subsequent chest compressions 
and defibrillation. 
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Figure 3. Receiver operating characteristic curves of CK, CK-MB, 
CK-MB/CK ratio (CK-MB%) and cTNT 12 h after admission for AMI 
after cardiac arrest and subsequent chest compressions and defibrilla- 
tion. 
ng/ml [IQR 0.07 to 0.42], p = 0.25). Twelve hours after cardiac 
arrest cTNT was higher in patients with Q wave MI (5.44 ng/ml 
[IQR 4.1 to 17.63] vs. 1.93 ng/ml [IQR 0.6 to 2.91], p -- 0.002). 
The amount of CK and CK-MB in patients with Q wave MI 
was 1,350 U/liter [IQR 486 to 2,100] and 93 U/liter [IQR 40 to 
184], respectively; in patients with non-Q wave M1 the amount 
of CK and CK-MB was 841 U/liter [IQR 486 to 2,100] and 99 
U/liter [IQR 36 to 130], respectively, which did not achieve 
statistical significance (p = 0.48 and p = 0.77, respectively). 
Diagnostic performance of CK, CK-MB, CK-MB/CK ratio 
and cTNT. On admission all markers of myocardial injury 
showed to be weak methods for the diagnosis of AMI (Fig. 2). 
The maximal Youden index for CK, CK-MB, CK-MB/CK ratio 
and cTNT was 0.23, 0.31, 0.28 and 0.36, respectively. The 
corresponding cutoff values were 86 U/liter, 18 U/liter, 7% and 
0.18 ng/ml, respectively, On admission CK exceeded the upper 
normal value of 80 U/liter in 15 patients with AMI and in 6 
patients without AMI; CK-MB exceeded 10 U/liter in 15 
patients with and in 5 without AMI; and cTNT exceeded 0.2 
ng/ml in 12 patients with and in 4 patients without AMI. After 
12 h, cTNT as well as CK-MB exhibited similar diagnostic 
performance, whereas CK and CK-MB/CK ratio proved to be 
almost worthless (Fig. 3). The maximal Youden index was 0.56, 
0.69, 0.3 and 0.76 for a CK, CK-MB, CK-MB/CK ratio and 
cTNT cutoff value of 564 U/liter, 26 U/liter, 7% and 0.6 ng/ml, 
respectively. Sensitivity and specificity for a cTNT cutoff value 
of 0.6 ng/ml were 96% and 80%, respectively, 12 h after cardiac 
arrest. For a CK-MB cutoff value of 26 U/liter, sensitivity and 
specificity were 96% and 73%, respectively. The upper normal 
value for CK and CK-MB, as well as a concentration f 0.2 
ng/ml for cTNT, was exceeded in all patients with AMI. In 
patients without AMI, the upper normal value for CK and 
CK-MB, as well as a concentration f 0.2 ng/ml for cTNT, was 
exceeded in 11 patients, 9 patients and 12 patients, respec- 
tively. 
Discuss ion  
The major finding of this study is that in patients resusci- 
tated from cardiac arrest, cTNT concentrations, a  well as the 
absolute amount of CK-MB, are good markers of myocardial 
injury to diagnose AMI. The CK-MB/CK ratio proved to be of 
poor diagnostic value in this setting. 
Elevations of serum CK and CK-MB in patients who had 
cardiac arrest and subsequent CPR are a frequent finding 
(3,4). However, in the two existing studies addressing this 
question, it could not be determined exactly whether CK and 
CK-MB elevations were due to skeletal muscular injury or 
myocardial injury, or both. Further, the value of CK and 
CK-MB to detect AMI could not be evaluated because of the 
study design. The present study is, to the best of our knowl- 
edge, the first study to determine the diagnostic value of 
CK-MB and cTNT to diagnose AMI after cardiac arrest. 
Diagnostic performance of CK, CK-MB, CK-MB/CK ratio 
and cTNT. Currently cTNT is said to be as sensitive as but less 
specific than CK-MB for retrospective diagnosis of AMI (20). 
In a recent meta-analysis Wu and Lane (20) demonstrated a 
sensitivity of 97% for CK-MB and 98% for cTNT to detect 
AMI. Specificity for CK-MB and cTNT in this meta-analysis 
was 90% and 69%, respectively. It is important to mention that 
specificity for cTNT in this setting refers to the acuteness and 
probably also the severity of the event, not to the specificity for 
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cardiac tissue. The high cardiospecificity of cTNT has already 
been demonstrated in several studies (16,21-25). After MI, 
serum cTNT levels are known to be elevated for up to several 
days (16-17,25-26). This increases the time window to diag- 
nose MI by reducing the ability to differentiate b tween acute 
and subacute infarction. Further, it has been shown that cTNT 
is also detectable in some patients with unstable angina (22), 
which might precede MI. One recent study addressed the 
sensitivity and specificity, of cTNT in patients after out-of- 
hospital resuscitation (27). This group found a very high cTNT 
discriminator level of 4 ng/ml with a sensitivity of 88% and 
specificity of 95%. The shortcoming of this study (27) is the 
lack of a satisfactory reference standard for diagnosing AMI 
after out of hospital cardiac arrest. In our study we defined a
much lower cTNT discriminator level of 0.6 ng/ml to diagnose 
AMI. If we applied a cutoff value of 3.2 ng/ml, the specificity 
would be 100% with a corresponding sensitivity of 58%. The 
cutoff values to diagnose AMI in patients without CPR ranged 
from 0.1 to 0.5 ng/ml (16,23,25). When we applied a cutoff 
value of 0.6 ng/ml 12 h after the event we found both a higher 
sensitivity and specificity for cTNT in comparison to CK-MB. 
Also, the cutoff concentration of 26 U/liter for CK-MB to 
detect AMI is more than twice the upper normal value than 
that applied in patients without CPR. It is also noteworthy that 
cTNT concentrations were elevated >0.2 ng/ml in 12 of 15 
(80%) patients without AMI 12 h after cardiac arrest. This 
implies that a qualitative stimation of cTNT in this patient 
group is not useful to diagnose AMI unless the discriminator 
value is set at a level >0.2 ng/ml. 
On admission none of the variables seemed to be of 
diagnostic value for the diagnosis of AMI, which has already 
been described (28,29). All three markers frequently exceeded 
established upper normal values. For CK and CK-MB this 
already has been shown (4). The concomitant elevation of 
cTNT indicates cardiac damage. However, whether this eleva- 
tion serves as an indicator of unrecognized MI before cardiac 
arrest or of severe myocardial damage due to cardiac arrest 
and CPR remains unclear. Admission concentrations in pa- 
tients with MI were higher at least. 
Total CK and CK-MB/CK ratio turned out to be useless 
tools in the diagnosis of AMI after CPR even 12 h after the event. 
Besides AMI as the cause of cardiac arrest, myocardial 
injury in cardiac arrest patients might be caused by several 
factors. During cardiac arrest coronary blood flow is presumed 
to be absent before initiation of life support herapy. During 
CPR coronary perfusion pressure is reduced to -10% to 20% 
of control values (30,31), both factors probably causing isch- 
emic damage. It is also known that defibrillation can cause 
myocardial muscular damage (32). There is also the possibility 
of cardiac ontusion due to chest compressions. Further, CK 
and CK-MB elevations might in part also be caused by skeletal 
muscular injury due to resuscitative efforts. Another possible 
cause for myocardial damage might be persistent circulatory 
shock, which is not rare after cardiac arrest with primary 
successful resuscitation. The design of this study did not allow 
us to determine which of these factors was responsible for 
CK-MB and cTNT elevations. Excess release of CK from 
skeletal muscles can produce afalse normal CK-MB/CK ratio, 
which is a plausible xplanation for the low diagnostic value of 
CK and CK-MB/CK ratio in this patient group. The cross 
reactivity of cTNT with striated skeletal muscle is expected to 
be <0.5% (24). Therefore, cTNT was already successfully used 
to identify increases in CK-MB after physical exercise as 
noncardiac (21) and also to detect cardiac ontusion (33). This 
might explain the higher sensitivity and specificity of cTNT to 
diagnose AM1 in patients after cardiac arrest and CPR. 
When we compared patients with AMI and subsequent Q 
wave formation on the ECG to patients with AMI but without 
Q wave formation, we found higher cTNT levels in the former 
group--probably a measure of infarct size, for the extent of MI is 
known to be larger if there is Q wave formation (34). The reason 
why CK and CK-MB did not differ significantly between these 
groups is most probably the higher myocardial specificity ofcTNT 
as well as a reduced statistical power because of small subgroups. 
Study limitations. To create a reference standard to diag- 
nose AMI in our patient group we had to apply several 
diagnostic tools. Autopsy is presumed to be the reference 
standard for most diagnostic procedures (35). All our patients 
survived for more than 12 h, so we expect a coagulation 
necrosis to be detectable. As for thallium-201 myocardial 
imaging we presumed AMI only if the patient had irreversible 
perfusion defects with a sensitivity close to 100% and a 
specificity -68% (36,37). The possibility that a patient had an 
unrecognized MI before the event, and thus did not fulfill the 
exclusion criteria, also might limit the diagnostic performance 
of the biochemical markers used in this study. Another limita- 
tion of the study is the retrospective evaluation of the prehos- 
pital data. Difficulties in conducting clinical studies in cardiac 
arrest patients are numerous and well recognized (8). We 
could not do better than using an internationally recognized 
protocol (8) especially designed for the evaluation of prehos- 
pital cardiac arrest data, and assessing the data immediately 
after arrival in the emergency department. 
Conclusions. Although both cTNT and CK-MB are valu- 
able tools in detecting AMI as the cause of sudden cardiac 
death, there is a considerable ack of sensitivity and specificity, 
respectively. It is questionable whether other markers of 
myocardial injury will give more accurate results, for cardiac 
injury might not be caused only by AMI but also by myocardial 
damage related to cardiac arrest and CPR efforts. 
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